Novalung® On Demand Webinar
 

Management and Mobilization of Veno-venous ECMO Patients
 

Building a successful ECMO program often means understanding acute respiratory failure and the use of ECMO to support patients with complex or multiple comorbidities. Do you ambulate or mobilize your ECMO patients with this or other complex conditions? If you want to learn more about options during veno-venous ECMO, please join Dr. Jason Wells as he shares his experiences supporting patients with ARDS and COVID-19 while identifying mobilization strategies that can be easily implemented by healthcare professionals and could be beneficial for the patient. Live Q&A session to follow.

Register to watch this 45 minute webinar and you will learn about:

  • Acute respiratory failure
  • Extracorporeal membrane oxygenation or ECMO
  • Veno-venous support during COVID-19
  • Portable technologies for extracorporeal life support (ECLS)
  • Complications during ECLS 
  • Mobilization strategies during ECMO

 

About the Presenter:
 

Dr. Jason Wells, Pulmonary and Critical Care Medicine


Jason Wells, MD*
Pulmonary and Critical Care Medicine
Providence Portland Medical Center and The Oregon Clinic

Dr. Jason Wells graduated with High Distinction from The University of Michigan and completed his MD at Weill Medical College of Cornell University in New York City, NY. He later completed his residency in Internal Medicine at University of Wisconsin Hospitals and Clinics in Madison, WI as well as a Pulmonary and Critical Care Fellowship at University of Colorado Health Science Center, Denver, CO. Dr. Wells is a Pulmonologist at The Oregon Clinic Pulmonary, Critical Care & Sleep Medicine.  He has served as the Medical Director of the Providence ARDS Center with ECMO since 2018.

*Paid speaker for Fresenius Medical Care North America

 

 

Watch Webinar now

Complete this form to register for the webcast.


 

 

INDICATIONS FOR USE

The Novalung System is indicated for long-term (>6 hours) respiratory/cardiopulmonary support that provides assisted extracorporeal circulation and physiologic gas exchange (oxygenation and CO2 removal) of the patient’s blood in adults with acute respiratory failure or acute cardiopulmonary failure, where other available treatment options have failed, and continued clinical deterioration is expected or the risk of death is imminent. These may include:

  • Failure to wean from cardiopulmonary bypass following cardiac surgery in adult patients
  • ECMO-assisted cardiopulmonary resuscitation in adults
     

Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.
Note: Read the Instructions for Use for safe and proper use of these devices. The Indications for Use for this device can be found at https://fmcna.com/products/indications-safety-and-warnings.

© 2021 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo and Novalung are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. P/N 104788-01 Rev A 07/2021